Sentinel Initiative Public Workshop The Brookings Institution Marriott Wardman Park Washington, DC January 31, 2013
Development of the Sentinel System through Public-Private Collaboration FDA awards Mini-Sentinel Brookings able to query FDAAA convener grant Sentinel Initiative data from 126 announced million individuals FDA awards HPHC Brookings Brookings Brookings Mini-Sentinel Public Public Public contract Workshop Workshop Workshop FDASIA 2007 2008 2009 2010 2011 2012 2013 Brookings Brookings OMOP FDA awards 8 Public Public launched small project Workshop Workshop contracts Assessment Assessment completed: initiated: Angioedema events and Myocardial drugs that target the renin- Infarction and Oral angiotensin-aldosterone Hypoglycemics system
Public Workshop Agenda •The Sentinel Initiative: Ongoing Progress and Future Directions •State of Mini-Sentinel Activities •Selected Mini-Sentinel Protocol Driven Evaluations •Collaborations Supporting Active Surveillance Research •Planned Expansion of Prospective Surveillance Program •Opportunities to Expand the Public Health Impact of the Sentinel Initiative •Stakeholder Feedback: Mini-Sentinel as a Tool for Evaluating Drug Safety Issues that Require Regulatory Action
Recommend Documents
Sentinel Initiative Public Workshop Monday, January 11, 2010 Mark McClellan,
Opportunities to Expand the Public Health Impact of the Sentinel Initiative
Mini-Sentinel from Vision to Reality: A Patient Representatives Perspective
5/17/2013 Topics for Discussion What is a sentinel lymph node (SLN)? Utility
MONTANA DEPARTMENT OF CORRECTIONS + COVID-19 RESPONSE UPDATE LAW AND JUSTICE
Mini-Sentinel Common Data Model Lesley Curtis on behalf of the Mini-Sentinel
How CDER is Using Mini-Sentinel Tools and Resources for Post-Marketing Safety
Sentinel Landscapes Sentinel Landscapes are working or natural lands important
Status of Sentinel-1 and acquisition plans for GFOI Frank Martin Seifert,
Sentinel Mine & Enterprise Project Analyst presentation October 2015 1
The STARS Paper The Paper and the Process Your job while you are here: 1.
Asian Chapter Asian Chapter Achieving Blood Pressure targets: Current &
Lights, Cam era, ( Vaso) Action! Vasoactive Agents for Catecholam ine
Disclaimer This presentation document has been prepared by Renalytix AI plc
A Leader Redefining How Kidney Disease is Treated Investor Presentation July
Novel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple
MACRA: Preparing for the Road Ahead George Mayzell, MD MBA Chief Clinical
10/10/2015 Peripheral Vascular Disease Ganesh Muthappan, MD, FACC
DEVELOPING NOVEL, FIRST-IN-CLASS CARDIOVASCULAR DRUGS Corporate Presentation
International Journal of Clinical Rheumatology Case Report Elevated alkaline
Development of a Policy Toolkit to Inform Canadian Policymakers Regarding
15-03-31 University of Calgary GI Luminal Clinician ScienJsts